Edition:
United States

Genomic Health Inc (GHDX.O)

GHDX.O on Nasdaq

30.85USD
21 Sep 2017
Change (% chg)

$-0.30 (-0.96%)
Prev Close
$31.15
Open
$31.17
Day's High
$31.26
Day's Low
$30.82
Volume
70,374
Avg. Vol
110,217
52-wk High
$33.97
52-wk Low
$26.37

Select another date:

Wed, Sep 13 2017

BRIEF-Genomic Health and Biocartis announce agreement to develop a breast cancer test

* ‍GENOMIC HEALTH AND BIOCARTIS ANNOUNCE AGREEMENT TO DEVELOP AN IDYLLA(TM) IVD ONCOTYPE DX(®) BREAST CANCER TEST TO BROADEN GLOBAL PATIENT ACCESS​

BRIEF-Palmetto GBA issues positive final local coverage determination to expand medicare coverage of Oncotype DX genomic prostate score test

* Palmetto GBA issued positive final local coverage determination to expand medicare coverage of Oncotype DX genomic prostate score test Source text for Eikon: Further company coverage:

BRIEF-Genomic Health Q2 loss per share $0.08

* Genomic Health announces second quarter 2017 financial results and reports recent business progress

BRIEF-Genomic Health Q1 revenue $84 million

* Genomic Health announces first quarter 2017 financial results and reports recent business progress

Select another date: